Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation Platform
Cellebrite DI (NASDAQ:CLBT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
How Do Cellebrite DI's New Partnerships Impact Its Value After a 19.8% Price Jump? [Yahoo! Finance]
Cellebrite (CLBT) Jumps 20.7% on Stellar Q3 [Yahoo! Finance]
Cellebrite DI (NASDAQ:CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $23.00 to $24.00. They now have an "overweight" rating on the stock.